Piramal signs PET agent deal with Ci-Co Healthcare

By AuntMinnie.com staff writers

November 21, 2013 -- Piramal Imaging has entered into a strategic partnership with Ci-Co Healthcare.

The deal includes an exclusive licensing agreement for Ci-Co Healthcare to obtain market authorization from the Korean Health Authorities and commercialize Piramal's PET amyloid imaging agent F-18 florbetaben in South Korea.

Ci-Co has assigned the manufacturing and supply of the agent to DuChemBio, a radiopharmacy network in South Korea.


Copyright © 2013 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
What's this?
Sign in using your social networking
account:
(What's this?)


Forgot your password?
|
View our privacy policy.